Sector
PharmaceuticalsOpen
₹238Prev. Close
₹237.52Turnover(Lac.)
₹955.98Day's High
₹253.57Day's Low
₹233.5452 Week's High
₹263.7352 Week's Low
₹108.1Book Value
₹64.33Face Value
₹1Mkt Cap (₹ Cr.)
2,119.94P/E
40.63EPS
5.84Divi. Yield
08 Aug 2023
12:00 AM
BookCloser
8 Aug 2023
12:00 AM
AGM
Announcement Date: 08 Aug, 2023
13 Feb 2024
12:00 AM
EGM
25 May 2023
12:00 AM
Dividend
Dividend Amount: 0.3
Record Date: 22 Sep, 2023
22 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 8.47 | 8.47 | 8.47 | 8.47 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 486.63 | 485.3 | 419.76 | 358.96 |
Net Worth | 495.1 | 493.77 | 428.23 | 367.43 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 563.17 | 411.94 | 462.67 | 438.12 |
yoy growth (%) | 36.71 | -10.96 | 5.6 | -27.36 |
Raw materials | -339.99 | -246.36 | -289.89 | -295.84 |
As % of sales | 60.37 | 59.8 | 62.65 | 67.52 |
Employee costs | -41.17 | -39.35 | -32.8 | -26.92 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 91.11 | 50.75 | 60.34 | 41.58 |
Depreciation | -22.28 | -22.06 | -19.89 | -19.17 |
Tax paid | -30.15 | -18.06 | -19.89 | -5.96 |
Working capital | 60.27 | 35.89 | 36.48 | -52.78 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 36.71 | -10.96 | 5.6 | -27.36 |
Op profit growth | 51.54 | -14.37 | 24.78 | -16.14 |
EBIT growth | 62.43 | -16.96 | 32.87 | -22.21 |
Net profit growth | 86.5 | -19.19 | 13.58 | -14.46 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 709.26 | 522.05 | 519.87 | 563.18 | 411.95 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 709.26 | 522.05 | 519.87 | 563.18 | 411.95 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 4.46 | 4.91 | 5.2 | 3.45 | 5.11 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
P Ramesh Babu
Independent Director
P Sarath Kumar
Independent Director
Thummala Neelaveni
Independent Director
Shravan Kudaravalli
Independent Director
Sarvepalli Srinivas
Executive Director
Vamsi Krishna Potluri
Company Sec. & Compli. Officer
Thirumalesh Tumma
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by SMS Pharmaceuticals Ltd
Summary
SMS Pharmaceuticals Limited is a Public company incorporated in December 14, 1987. The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates. Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa in Vijayanagaram Dist. Its business activity is a single primary business segment of Bulk Drugs. During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities.During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24.During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs. 10/- each in M/s. VKT Pharma Private Limited. With this the said company has become an associate company. The project of the said associate company is in final stage and at the verge of completion and operations are yet to be commenced. The Company has not having any subsidiaries.During the year 2015-16, the Company had sub divided the face value of share of Rs 10/- each into face value of Rs 1/- of each with record date of 18th December 2015.During FY 2015-16, the Board has approved the Draft Scheme of Arrangement for Demerger of Semi Regulated Units (Unit - I, IV & V) along with other Assets to transfer the same to SMS Lifesciences India Limited (Resulting Company), with an object
Read More
What is the SMS Pharmaceuticals Ltd share price today?
The SMS Pharmaceuticals Ltd shares price on N/A is Rs.₹251.75 today.
What is the Market Cap of SMS Pharmaceuticals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of SMS Pharmaceuticals Ltd is ₹2131.11 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of SMS Pharmaceuticals Ltd?
The PE and PB ratios of SMS Pharmaceuticals Ltd is 40.63 and 3.52 as of 22 Jul ‘24
What is the 52 Week High and Low of SMS Pharmaceuticals Ltd?
The 52-week high/low is the highest and lowest price at which a SMS Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of SMS Pharmaceuticals Ltd is ₹105 and ₹265 as of 22 Jul ‘24
What is the CAGR of SMS Pharmaceuticals Ltd?
SMS Pharmaceuticals Ltd's CAGR for 5 Years at 37.21%, 3 Years at 7.64%, 1 Year at 110.41%, 6 Month at 88.93%, 3 Month at 15.11% and 1 Month at 9.86%.
What is the shareholding pattern of SMS Pharmaceuticals Ltd?
The shareholding pattern of SMS Pharmaceuticals Ltd is as follows:
Promoters - 64.67 %
Institutions - 2.30 %
Public - 33.03 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
